Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial by van de Velde, Cornelis JH, Prof, Rea, Daniel, MD, Seynaeve, Caroline, MD, Putter, Hein, Prof, Hasenburg, Annette, Prof, Vannetzel, Jean-Michel, MD, Paridaens, Robert, Prof, Markopoulos, Christos, Prof, Hozumi, Yasuo, MD, Hille, Elysee TM, PhD, Kieback, Dirk G, MD, Asmar, Lina, PhD, Smeets, Jan, BSc, Nortier, Johan WR, Prof, Hadji, Peyman, Prof, Bartlett, John MS, PhD, Jones, Stephen E, MD

Get full text

Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking by Scher, Nathaniel, Bollet, Marc, Bouilhol, Gauthier, Tannouri, Remi, Khemiri, Imane, Vouillaume, Aurelie, Sellami, Noura, Von Eyben, Rie, Vannetzel, Jean-Michel, Darmon, Ilan, Rotenberg, Luc, Lamallem, Hanah, Bauduceau, Olivier, Foster, Denis, Toledano, Alain

Get full text

Results of PONDx, a prospective multicenter study of the Oncotype DX® breast cancer assay: Real-life utilization and decision impact in French clinical practice by Curtit, Elsa, Vannetzel, Jean-Michel, Darmon, Jean-Claude, Roche, Sophie, Bourgeois, Hugues, Dewas, Sylvain, Catala, Stéphanie, Mereb, Emile, Fanget, Charlotte Furtos, Genet, Dominique, Forest, Anne-Marie, Bernier, Céline, Pivot, Xavier

Get full text

Advances in the Use of Taxanes in the Adjuvant Therapy of Breast Cancer by Nabholtz, Jean-Marc, Vannetzel, Jean-Michel, Llory, Jean-Francois, Bouffette, Patrick

Get full text

Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Meta... by Lévi, Francis A., Zidani, Rachid, Vannetzel, Jean-Michel, Perpoint, Bruno, Focan, Christian, Faggiuolo, Roberto, Chollet, Philippe, Garufi, Carlo, Itzhaki, Moshe, Dogliotti, Luigi, lacobelli, Stefano, Adam, René, Kunstlinger, Francis, Gastiaburu, Julio, Bismuth, Henri, Jasmin, Claude, Misset, Jean-Louis

Get full text

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial by Quoix, Elisabeth, Prof, Zalcman, Gérard, Prof, Oster, Jean-Philippe, MD, Westeel, Virginie, Prof, Pichon, Eric, MD, Lavolé, Armelle, MD, Dauba, Jérôme, MD, Debieuvre, Didier, MD, Souquet, Pierre-Jean, MD, Bigay-Game, Laurence, MD, Dansin, Eric, MD, Poudenx, Michel, MD, Molinier, Olivier, MD, Vaylet, Fabien, MD, Moro-Sibilot, Denis, Prof, Herman, Dominique, MD, Bennouna, Jaafar, MD, Tredaniel, Jean, Prof, Ducoloné, Alain, MD, Lebitasy, Marie-Paule, MD, Baudrin, Laurence, MSc, Laporte, Silvy, PhD, Milleron, Bernard, MD

Get full text

Can we predict chemo-induced hematotoxicity in elderly patients treated with pegylated liposomal doxorubicin? Results of a population-based model derived from the DOGMES phase II t... by Sostelly, Alexandre, Henin, Emilie, Chauvenet, Laure, Hardy-Bessard, Anne-Claire, Jestin-Le Tallec, Véronique, Kirsher, Sylvie, Leyronnas, Cécile, Ligeza-Poisson, Catherine, Ramdane, Soraya, Salavt, Jacques, Van-Hult, Sylvie, Vannetzel, Jean-Michel, Freyer, Gilles, Tod, Michel, Falandry, Claire

Get full text

Multicentre randomised phase II trial of gemcitabine + platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2 by Oudard, Stéphane, Culine, Stéphane, Vano, Yann, Goldwasser, François, Théodore, Christine, Nguyen, Thierry, Voog, Eric, Banu, Eugeniu, Vieillefond, Annick, Priou, Franck, Deplanque, Gaël, Gravis, Gwenaëlle, Ravaud, Alain, Vannetzel, Jean Michel, Machiels, Jean-Pascal, Muracciole, Xavier, Pichon, Marie-France, Bay, Jacques-Olivier, Elaidi, Reza, Teghom, Corine, Radvanyi, François, Beuzeboc, Philippe

Get full text

A prospective study of detorubicin in malignant mesothelioma by Colbert, Nicolas, Vannetzel, Jean‐Michel, Izrael, Victor, Schlienger, Michel, Milleron, Bernard, Blanchon, Francois, Herman, Dominique, Akoun, Georges, Roland, Jean, Chatelet, Francois, Laugier, Alain

Get full text